AR and liver cancer: The results indicate that 10–90 μM fisetin did not reduce the cell proliferation of Clone 9 (Figure 1A), however it significantly attenuated the proliferation of HA22T parental cells, and especially AR and SR liver cancer cells in a dose-dependent manner (Figure 1B).